You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 278 No. 20, November 26, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Controversies
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Short-Course Antimicrobial Treatment for Acute Otitis Media

Not Best for Infants and Young Children

Jack L. Paradise, MD

JAMA. 1997;278(20):1640-1642.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN RECENT years a number of authors—this author among them—have called for restricting, in varying degree, the use of antimicrobials in treating otitis media.1-5 Two factors have prompted these recommendations: compelling evidence that selective pressure from antimicrobial use contributes importantly to the rising prevalence of infections caused by multidrug resistant Streptococcus pneumoniae,6,7 and the fact that otitis media accounts for a large proportion of all antimicrobial use. For example, in 1986, of 44.5 million office-based prescriptions for antimicrobials for children younger than 10 years, 42% were for otitis media8; while in 1990,1 or more drugs—mainly antimicrobials—were prescribed at more than 80% of the estimated 24.5 million visits to physicians' offices for otitis media.9,10 Of those visits, children younger than 2 years accounted for 33.3%; children aged 2 to 5 years, 29.2%; and children aged 6 to 14 years, 17.9%.9 In a recent prospective study, antimicrobial . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pa.

Dr Paradise has received honoraria and research support from SmithKline Beecham Pharmaceuticals, Philadelphia, Pa, and Pfizer Inc, New York, NY, as well as consultation fees from SmithKline Beecham.


Footnotes

Reprints: Jack L. Paradise, MD, Children's Hospital of Pittsburgh, 3705 Fifth Ave, Pittsburgh, PA 15213-2583.

Controversies section editor: Phil B. Fontanarosa, MD, Senior Editor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Controversies: Treatment of Acute Otitis Media
Michael J. Harkness, Asa Melhus, Ann Hermansson, Richard M. Rosenfeld, Jack L. Paradise, Jack Froom, Larry Culpepper, and Jack L. Paradise
JAMA. 1998;279(22):1783-1785.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.